1. Home
  2. AVLN vs NAT Comparison

AVLN vs NAT Comparison

Compare AVLN & NAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avalyn Pharma Inc. Common Stock

AVLN

Avalyn Pharma Inc. Common Stock

N/A

Current Price

$29.89

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Nordic American Tankers Limited

NAT

Nordic American Tankers Limited

N/A

Current Price

$6.72

Market Cap

1.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
AVLN
NAT
Founded
2011
1995
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.6B
IPO Year
2026
1997

Fundamental Metrics

Financial Performance
Metric
AVLN
NAT
Price
$29.89
$6.72
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
★ $61.80
$8.50
AVG Volume (30 Days)
432.2K
★ 4.4M
Earning Date
11-12-2026
11-30-2026
Dividend Yield
N/A
★ 6.99%
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$3.38
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$525.49
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$3.33
52 Week High
$40.17
$8.88

Technical Indicators

Market Signals
Indicator
AVLN
NAT
Relative Strength Index (RSI) 58.89 38.52
Support Level $25.86 $6.41
Resistance Level $33.32 $7.20
Average True Range (ATR) 1.93 0.33
MACD 0.67 -0.09
Stochastic Oscillator 74.04 29.67

Price Performance

Historical Comparison
AVLN
NAT

About AVLN Avalyn Pharma Inc. Common Stock

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases (ILDs). Its current pipeline is focused on treating pulmonary fibrosis, a life-threatening disease with a median survival of three to five years, which is a significantly shorter prognosis than that observed for many forms of cancer. Its flagship programs include AP01 and AP02, which are inhaled formulations of pirfenidone and nintedanib being developed for conditions such as progressive pulmonary fibrosis and idiopathic pulmonary fibrosis. The company has one operating and reportable segment, which is the business of developing and commercializing targeted therapies for rare lung diseases.

About NAT Nordic American Tankers Limited

Nordic American Tankers Ltd owns and operates double-hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters according to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.

Share on Social Networks: